A Neuronal Isoform of Nitric Oxide Synthase Expressed in Pancreatic β-Cells Controls Insulin Secretion
Open Access
- 1 June 2001
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 50 (6) , 1311-1323
- https://doi.org/10.2337/diabetes.50.6.1311
Abstract
Evidence is presented showing that a neuronal isoform of nitric oxide synthase (NOS) is expressed in rat pancreatic islets and INS-1 cells. Sequencing of the coding region indicated a 99.8% homology with rat neuronal NOS (nNOS) with four mutations, three of them resulting in modifications of the amino acid sequence. Double-immunofluorescence studies demonstrated the presence of nNOS in insulin-secreting β-cells. Electron microscopy studies showed that nNOS was mainly localized in insulin secretory granules and to a lesser extent in the mitochondria and the nucleus. We also studied the mechanism involved in the dysfunction of the β-cell response to arginine and glucose after nNOS blockade with NG-nitro-l-arginine methyl ester. Our data show that miconazole, an inhibitor of nNOS cytochrome c reductase activity, either alone for the experiments with arginine or combined with sodium nitroprusside for glucose, is able to restore normal secretory patterns in response to the two secretagogues. Furthermore, these results were corroborated by the demonstration of a direct enzyme-substrate interaction between nNOS and cytochrome c, which is strongly reinforced in the presence of the NOS inhibitor. Thus, we provide immunochemical and pharmacological evidence that β-cell nNOS exerts, like brain nNOS, two catalytic activities: a nitric oxide production and an NOS nonoxidating reductase activity, both of which are essential for normal β-cell function. In conclusion, we suggest that an imbalance between these activities might be implicated in β-cell dysregulation involved in certain pathological hyperinsulinic states.Keywords
This publication has 62 references indexed in Scilit:
- Endogenous Nitric Oxide Inhibits Glucose-Induced Insulin Secretion by Suppression of Phosphofructokinase Activity in Pancreatic IsletsBiochemical and Biophysical Research Communications, 1998
- Mechanisms involved in the effect of nitric oxide synthase inhibition on L‐arginine‐induced insulin secretionBritish Journal of Pharmacology, 1997
- Effects of the Nitric Oxide Synthase Inhibitor NωNitro-l-arginine Methyl Ester on Electrical Activity and Ion Channels of Mouse Pancreatic B CellsBiochemical and Biophysical Research Communications, 1996
- Nitric Oxide (Nitrogen Monoxide, No) Stimulates Insulin Secretion by Inducing Calcium Release from MitochondriaBiochemical and Biophysical Research Communications, 1995
- Nω-Hydroxy-L-Arginine, an Intermediate in the L-Arginine to Nitric Oxide Pathway, Is a Strong Inhibitor of Liver and Macrophage ArginaseBiochemical and Biophysical Research Communications, 1994
- Comparison of Substrate and Inhibitor Specificity of Arginase and Nitricm Oxide (NO) Synthase for Arginine Analogs and Related Compounds in Murine and Rat MacrophagesBiochemical and Biophysical Research Communications, 1994
- Nitric Oxide and Arginine-Evoked Insulin SecretionScience, 1992
- Nitric oxide: A cytotoxic activated macrophage effector moleculeBiochemical and Biophysical Research Communications, 1988
- L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxationBiochemical and Biophysical Research Communications, 1988
- Etude expérimentale d'un nouveau sulfamide hypoglycémiant particulièrement actif, le HB 419 ou glibenclamideDiabetologia, 1969